HCA Data Explorer

A human breast atlas integrating single-cell proteomics and transcriptomics

Updated January 23, 2023

The breast is a dynamic organ whose response to physiological and pathophysiological conditions alters its disease susceptibility, yet the specific effects of these clinical variables on cell state remain poorly annotated. We present a unified, high-resolution breast atlas by integrating single-cell RNA-seq, mass cytometry, and cyclic immunofluorescence, encompassing a myriad of states. We define cell subtypes within the alveolar, hormone-sensing, and basal epithelial lineages, delineating associations of several subtypes with cancer risk factors, including age, parity, and BRCA2 germline mutation. Of particular interest is a subset of alveolar cells termed basal-luminal (BL) cells, which exhibit poor transcriptional lineage fidelity, accumulate with age, and carry a gene signature associated with basal-like breast cancer. We further utilize a medium-depletion approach to identify molecular factors regulating cell-subtype proportion in organoids. Together, these data are a rich resource to elucidate diverse mammary cell states. Overall design: A total of 16 breast samples were assayed (4 samples from reductive mammoplasties and 12 from prophylactic mastectomies).

Joan S BruggeDepartment of Cell Biology, Harvard Medical School (HMS), Boston, MA 02115, USAjoan_brugge@hms.harvard.edu
G Kenneth Gray1
Carman Man-Chung Li1
Jennifer M Rosenbluth2
Laura M Selfors1
Nomeda Girnius3
Jia-Ren Lin4
Ron C J Schackmann1
Walter L Goh1
Kaitlin Moore1
Hana K Shapiro1
Shaolin Mei4
Kurt D'Andrea5
Katherine L Nathanson5
Peter K Sorger4
Sandro Santagata6
Aviv Regev7
Judy E Garber8
Deborah A Dillon9
Joan S Brugge (Experimental Scientist)10
1Department of Cell Biology, Harvard Medical School (HMS), Boston, MA 02115, USA.
2Department of Cell Biology, Harvard Medical School (HMS), Boston, MA 02115, USA; Department of Medical Oncology, Dana-Farber Cancer Institute (DFCI), Boston, MA 02115, USA; Department of Medicine, University of California, San Francisco, San Francisco, CA 94143, USA.
3Department of Cell Biology, Harvard Medical School (HMS), Boston, MA 02115, USA; The Laboratory of Systems Pharmacology (LSP), HMS, Boston, MA 02115, USA.
4The Laboratory of Systems Pharmacology (LSP), HMS, Boston, MA 02115, USA.
5Department of Medicine, Division of Translation Medicine and Human Genetics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA.
6The Laboratory of Systems Pharmacology (LSP), HMS, Boston, MA 02115, USA; Department of Pathology, Brigham and Women's Hospital (BWH), Boston, MA 02115, USA.
7Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA.
8Department of Medical Oncology, Dana-Farber Cancer Institute (DFCI), Boston, MA 02115, USA.
9Department of Pathology, Brigham and Women's Hospital (BWH), Boston, MA 02115, USA.
10Department of Cell Biology, Harvard Medical School (HMS), Boston, MA 02115, USA
Rachel Schwartz

To reference this project, please use the following link:

https://explore.data.humancellatlas.dev.clevercanary.com/projects/9b876d31-0739-4e96-9846-f76e6a427279
None
INSDC Project Accessions:GEO Series Accessions:INSDC Study Accessions:

Atlas

None

Analysis Portals

CZ CELLxGENECZ CELLxGENE

Project Label

breastTranscriptomeAtlas

Species

Homo sapiens

Sample Type

specimens

Anatomical Entity

breast

Organ Part

Unspecified

Selected Cell Types

Unspecified

Disease Status (Specimen)

normal

Disease Status (Donor)

normal

Development Stage

human adult stage

Library Construction Method

10x 3' v2

Nucleic Acid Source

single cell

Paired End

false

Analysis Protocol

analysis_protocol_1, analysis_protocol_2

File Format

3 file formats

Cell Count Estimate

52.7k

Donor Count

16
csv.gz2 file(s)fastq.gz57 file(s)xlsx1 file(s)